{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:13:27Z","timestamp":1789647207028,"version":"4.0.0"},"publisher-location":"Cham","reference-count":70,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030471880","type":"print"},{"value":"9783030471897","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-47189-7_3","type":"book-chapter","created":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T19:02:44Z","timestamp":1603998164000},"page":"45-56","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Eph\/Ephrin Signaling in the Tumor Microenvironment"],"prefix":"10.1007","author":[{"given":"Katsuaki","family":"Ieguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Maru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"issue":"4834","key":"3_CR1","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.2825356","volume":"238","author":"H Hirai","year":"1987","unstructured":"Hirai H, Maru Y, Hagiwara K, Nishida J, Takaku F (1987) A novel putative tyrosine kinase receptor encoded by the eph gene. Science 238(4834):1717\u20131720","journal-title":"Science"},{"issue":"3","key":"3_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/cas.13942","volume":"110","author":"K Ieguchi","year":"2019","unstructured":"Ieguchi K, Maru Y (2019) Roles of EphA1\/A2 and ephrin-A1 in cancer. Cancer Sci 110(3):841\u2013848","journal-title":"Cancer Sci"},{"issue":"2","key":"3_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2174\/1871530315666150316121302","volume":"15","author":"K Ieguchi","year":"2015","unstructured":"Ieguchi K (2015) Eph as a target in inflammation. Endocr Metab Immune Disord Drug Targets 15(2):119\u2013128","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"11","key":"3_CR4","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1128\/MCB.10.11.5830","volume":"10","author":"LB Holzman","year":"1990","unstructured":"Holzman LB, Marks RM, Dixit VM (1990) A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol Cell Biol 10(11):5830\u20135838","journal-title":"Mol Cell Biol"},{"issue":"5","key":"3_CR5","first-page":"359","volume":"13","author":"C Johnson","year":"2016","unstructured":"Johnson C, Segovia B, Kandpal RP (2016) EPHA7 and EPHA10 physically interact and differentially co-localize in normal breast and breast carcinoma cell lines, and the co-localization pattern is altered in EPHB6-expressing MDA-MB-231 cells. Cancer Genomics Proteomics 13(5):359\u2013368","journal-title":"Cancer Genomics Proteomics"},{"issue":"6","key":"3_CR6","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1074\/jbc.M108011200","volume":"277","author":"A Freywald","year":"2002","unstructured":"Freywald A, Sharfe N, Roifman CM (2002) The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. J Biol Chem 277(6):3823\u20133828","journal-title":"J Biol Chem"},{"issue":"5","key":"3_CR7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0092-8674(00)81436-1","volume":"93","author":"HU Wang","year":"1998","unstructured":"Wang HU, Chen ZF, Anderson DJ (1998) Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93(5):741\u2013753","journal-title":"Cell"},{"issue":"2","key":"3_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/01.ATV.0000055440.89758.C2","volume":"23","author":"K Hamada","year":"2003","unstructured":"Hamada K, Oike Y, Ito Y, Maekawa H, Miyata K, Shimomura T et al (2003) Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells. Arterioscler Thromb Vasc Biol 23(2):190\u2013197","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"3_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrc2806","volume":"10","author":"EB Pasquale","year":"2010","unstructured":"Pasquale EB (2010) Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 10(3):165\u2013180","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3_CR10","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1158\/0008-5472.CAN-04-3388","volume":"65","author":"C Muller-Tidow","year":"2005","unstructured":"Muller-Tidow C, Diederichs S, Bulk E, Pohle T, Steffen B, Schwable J et al (2005) Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Cancer Res 65(5):1778\u20131782","journal-title":"Cancer Res"},{"issue":"10","key":"3_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/jcp.2006.041194","volume":"60","author":"R Holm","year":"2007","unstructured":"Holm R, Knopp S, Suo Z, Trope C, Nesland JM (2007) Expression of EphA2 and EphrinA-1 in vulvar carcinomas and its relation to prognosis. J Clin Pathol 60(10):1086\u20131091","journal-title":"J Clin Pathol"},{"issue":"9","key":"3_CR12","doi-asserted-by":"publisher","first-page":"e24426","DOI":"10.1371\/journal.pone.0024426","volume":"6","author":"DM Brantley-Sieders","year":"2011","unstructured":"Brantley-Sieders DM, Jiang A, Sarma K, Badu-Nkansah A, Walter DL, Shyr Y et al (2011) Eph\/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome. PLoS One 6(9):e24426","journal-title":"PLoS One"},{"issue":"2","key":"3_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccr.2005.07.005","volume":"8","author":"M Macrae","year":"2005","unstructured":"Macrae M, Neve RM, Rodriguez-Viciana P, Haqq C, Yeh J, Chen C et al (2005) A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 8(2):111\u2013118","journal-title":"Cancer Cell"},{"issue":"2","key":"3_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0092-8674(02)01015-2","volume":"111","author":"E Batlle","year":"2002","unstructured":"Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G et al (2002) Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB\/ephrinB. Cell 111(2):251\u2013263","journal-title":"Cell"},{"issue":"6","key":"3_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cell.2006.04.030","volume":"125","author":"J Holmberg","year":"2006","unstructured":"Holmberg J, Genander M, Halford MM, Anneren C, Sondell M, Chumley MJ et al (2006) EphB receptors coordinate migration and proliferation in the intestinal stem cell niche. Cell 125(6):1151\u20131163","journal-title":"Cell"},{"issue":"11","key":"3_CR16","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/ng.2007.11","volume":"39","author":"C Cortina","year":"2007","unstructured":"Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G et al (2007) EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet 39(11):1376\u20131383","journal-title":"Nat Genet"},{"issue":"14","key":"3_CR17","doi-asserted-by":"publisher","first-page":"5181","DOI":"10.1158\/1078-0432.CCR-05-0143","volume":"11","author":"AM Jubb","year":"2005","unstructured":"Jubb AM, Zhong F, Bheddah S, Grabsch HI, Frantz GD, Mueller W et al (2005) EphB2 is a prognostic factor in colorectal cancer. Clin Cancer Res 11(14):5181\u20135187","journal-title":"Clin Cancer Res"},{"issue":"7045","key":"3_CR18","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nature03626","volume":"435","author":"E Batlle","year":"2005","unstructured":"Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M et al (2005) EphB receptor activity suppresses colorectal cancer progression. Nature 435(7045):1126\u20131130","journal-title":"Nature"},{"issue":"9","key":"3_CR19","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1158\/0008-5472.CAN-08-3232","volume":"69","author":"SR Kumar","year":"2009","unstructured":"Kumar SR, Scehnet JS, Ley EJ, Singh J, Krasnoperov V, Liu R et al (2009) Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. Cancer Res 69(9):3736\u20133745","journal-title":"Cancer Res"},{"issue":"Pt 18","key":"3_CR20","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1242\/jcs.111.18.2741","volume":"111","author":"Z Nikolova","year":"1998","unstructured":"Nikolova Z, Djonov V, Zuercher G, Andres AC, Ziemiecki A (1998) Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci 111(Pt 18):2741\u20132751","journal-title":"J Cell Sci"},{"issue":"Pt 1","key":"3_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/jcs.115.1.25","volume":"115","author":"N Munarini","year":"2002","unstructured":"Munarini N, Jager R, Abderhalden S, Zuercher G, Rohrbach V, Loercher S et al (2002) Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. J Cell Sci 115(Pt 1):25\u201337","journal-title":"J Cell Sci"},{"issue":"9","key":"3_CR22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1440-169X.2009.01140.x","volume":"51","author":"S Weiler","year":"2009","unstructured":"Weiler S, Rohrbach V, Pulvirenti T, Adams R, Ziemiecki A, Andres AC (2009) Mammary epithelial-specific knockout of the ephrin-B2 gene leads to precocious epithelial cell death at lactation. Develop Growth Differ 51(9):809\u2013819","journal-title":"Develop Growth Differ"},{"issue":"4","key":"3_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/dgd.12126","volume":"56","author":"P Kaenel","year":"2014","unstructured":"Kaenel P, Hahnewald S, Wotzkow C, Strange R, Andres AC (2014) Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. Develop Growth Differ 56(4):255\u2013275","journal-title":"Develop Growth Differ"},{"issue":"8","key":"3_CR24","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/ncb1438","volume":"8","author":"NK Noren","year":"2006","unstructured":"Noren NK, Foos G, Hauser CA, Pasquale EB (2006) The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 8(8):815\u2013825","journal-title":"Nat Cell Biol"},{"issue":"13","key":"3_CR25","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1096\/fj.05-4038fje","volume":"19","author":"DM Brantley-Sieders","year":"2005","unstructured":"Brantley-Sieders DM, Fang WB, Hicks DJ, Zhuang G, Shyr Y, Chen J (2005) Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression. FASEB J 19(13):1884\u20131886","journal-title":"FASEB J"},{"issue":"21","key":"3_CR26","doi-asserted-by":"publisher","first-page":"10315","DOI":"10.1158\/0008-5472.CAN-06-1560","volume":"66","author":"DM Brantley-Sieders","year":"2006","unstructured":"Brantley-Sieders DM, Fang WB, Hwang Y, Hicks D, Chen J (2006) Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice. Cancer Res 66(21):10315\u201310324","journal-title":"Cancer Res"},{"issue":"10","key":"3_CR27","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1091\/mbc.e08-04-0378","volume":"20","author":"D Vaught","year":"2009","unstructured":"Vaught D, Chen J, Brantley-Sieders DM (2009) Regulation of mammary gland branching morphogenesis by EphA2 receptor tyrosine kinase. Mol Biol Cell 20(10):2572\u20132581","journal-title":"Mol Biol Cell"},{"issue":"1","key":"3_CR28","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1172\/JCI33154","volume":"118","author":"DM Brantley-Sieders","year":"2008","unstructured":"Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM et al (2008) The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling. J Clin Invest 118(1):64\u201378","journal-title":"J Clin Invest"},{"issue":"7","key":"3_CR29","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1158\/0008-5472.CAN-15-0847","volume":"76","author":"VM Youngblood","year":"2016","unstructured":"Youngblood VM, Kim LC, Edwards DN, Hwang Y, Santapuram PR, Stirdivant SM et al (2016) The Ephrin-A1\/EPHA2 signaling axis regulates glutamine metabolism in HER2-positive breast cancer. Cancer Res 76(7):1825\u20131836","journal-title":"Cancer Res"},{"issue":"4","key":"3_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbrc.2004.04.102","volume":"318","author":"BP Fox","year":"2004","unstructured":"Fox BP, Kandpal RP (2004) Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem Biophys Res Commun 318(4):882\u2013892","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3_CR31","first-page":"79","volume":"1","author":"J Walker-Daniels","year":"2002","unstructured":"Walker-Daniels J, Riese DJ 2nd, Kinch MS (2002) c-Cbl-dependent EphA2 protein degradation is induced by ligand binding. Mol Cancer Res 1(1):79\u201387","journal-title":"Mol Cancer Res"},{"issue":"14","key":"3_CR32","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1158\/0008-5472.CAN-06-0004","volume":"66","author":"H Guo","year":"2006","unstructured":"Guo H, Miao H, Gerber L, Singh J, Denning MF, Gilliam AC et al (2006) Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin. Cancer Res 66(14):7050\u20137058","journal-title":"Cancer Res"},{"issue":"1","key":"3_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","volume":"82","author":"J Folkman","year":"1990","unstructured":"Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82(1):4\u20136","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"3_CR34","first-page":"6449","volume":"49","author":"P Vaupel","year":"1989","unstructured":"Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49(23):6449\u20136465","journal-title":"Cancer Res"},{"issue":"6","key":"3_CR35","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9(6):677\u2013684","journal-title":"Nat Med"},{"issue":"2","key":"3_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/dbio.2000.0112","volume":"230","author":"NW Gale","year":"2001","unstructured":"Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM et al (2001) Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230(2):151\u2013160","journal-title":"Dev Biol"},{"issue":"2","key":"3_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1177\/0300060513478091","volume":"42","author":"J Bai","year":"2014","unstructured":"Bai J, Wang YJ, Liu L, Zhao YL (2014) Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation. J Int Med Res 42(2):405\u2013415","journal-title":"J Int Med Res"},{"issue":"7297","key":"3_CR38","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature08995","volume":"465","author":"S Sawamiphak","year":"2010","unstructured":"Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T et al (2010) Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465(7297):487\u2013491","journal-title":"Nature"},{"issue":"2","key":"3_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0378-1119(97)00562-3","volume":"207","author":"JJ Lin","year":"1998","unstructured":"Lin JJ, Jiang H, Fisher PB (1998) Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene 207(2):105\u2013110","journal-title":"Gene"},{"issue":"25","key":"3_CR40","doi-asserted-by":"publisher","first-page":"13683","DOI":"10.1073\/pnas.94.25.13683","volume":"94","author":"JJ Grootjans","year":"1997","unstructured":"Grootjans JJ, Zimmermann P, Reekmans G, Smets A, Degeest G, Durr J et al (1997) Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci U S A 94(25):13683\u201313688","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"3_CR41","doi-asserted-by":"publisher","first-page":"38886","DOI":"10.18632\/oncotarget.16452","volume":"8","author":"N Tae","year":"2017","unstructured":"Tae N, Lee S, Kim O, Park J, Na S, Lee JH (2017) Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells. Oncotarget 8(24):38886\u201338901","journal-title":"Oncotarget"},{"issue":"30","key":"3_CR42","doi-asserted-by":"publisher","first-page":"46848","DOI":"10.18632\/oncotarget.10040","volume":"7","author":"SK Das","year":"2016","unstructured":"Das SK, Guo C, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN et al (2016) Knockout of MDA-9\/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis. Oncotarget 7(30):46848\u201346861","journal-title":"Oncotarget"},{"issue":"3","key":"3_CR43","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1158\/1541-7786.MCR-14-0142","volume":"13","author":"V Youngblood","year":"2015","unstructured":"Youngblood V, Wang S, Song W, Walter D, Hwang Y, Chen J et al (2015) Elevated Slit2 activity impairs VEGF-induced angiogenesis and tumor neovascularization in EphA2-deficient endothelium. Mol Cancer Res 13(3):524\u2013537","journal-title":"Mol Cancer Res"},{"issue":"12","key":"3_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.5483\/BMBRep.2012.45.12.236","volume":"45","author":"CK Heo","year":"2012","unstructured":"Heo CK, Bahk YY, Cho EW (2012) Tumor-associated autoantibodies as diagnostic and prognostic biomarkers. BMB Rep 45(12):677\u2013685","journal-title":"BMB Rep"},{"issue":"17","key":"3_CR45","first-page":"4855","volume":"60","author":"R Chiari","year":"2000","unstructured":"Chiari R, Hames G, Stroobant V, Texier C, Maillere B, Boon T et al (2000) Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules. Cancer Res 60(17):4855\u20134863","journal-title":"Cancer Res"},{"issue":"15","key":"3_CR46","first-page":"4481","volume":"63","author":"T Tatsumi","year":"2003","unstructured":"Tatsumi T, Herrem CJ, Olson WC, Finke JH, Bukowski RM, Kinch MS et al (2003) Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Cancer Res 63(15):4481\u20134489","journal-title":"Cancer Res"},{"issue":"1","key":"3_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1479-5876-2-40","volume":"2","author":"M Hatano","year":"2004","unstructured":"Hatano M, Kuwashima N, Tatsumi T, Dusak JE, Nishimura F, Reilly KM et al (2004) Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors. J Transl Med 2(1):40","journal-title":"J Transl Med"},{"issue":"7","key":"3_CR48","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/cncr.22958","volume":"110","author":"S Yamaguchi","year":"2007","unstructured":"Yamaguchi S, Tatsumi T, Takehara T, Sakamori R, Uemura A, Mizushima T et al (2007) Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines. Cancer 110(7):1469\u20131477","journal-title":"Cancer"},{"issue":"12","key":"3_CR49","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1007\/s00262-008-0514-5","volume":"57","author":"S Yamaguchi","year":"2008","unstructured":"Yamaguchi S, Tatsumi T, Takehara T, Sasakawa A, Hikita H, Kohga K et al (2008) Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity. Cancer Immunol Immunother 57(12):1861\u20131869","journal-title":"Cancer Immunol Immunother"},{"issue":"23","key":"3_CR50","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/j.biomaterials.2007.04.023","volume":"28","author":"T Akagi","year":"2007","unstructured":"Akagi T, Wang X, Uto T, Baba M, Akashi M (2007) Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives. Biomaterials 28(23):3427\u20133436","journal-title":"Biomaterials"},{"issue":"8","key":"3_CR51","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1163\/156856206777996871","volume":"17","author":"T Akagi","year":"2006","unstructured":"Akagi T, Kaneko T, Kida T, Akashi M (2006) Multifunctional conjugation of proteins on\/into bio-nanoparticles prepared by amphiphilic poly(gamma-glutamic acid). J Biomater Sci Polym Ed 17(8):875\u2013892","journal-title":"J Biomater Sci Polym Ed"},{"key":"3_CR52","first-page":"75","volume":"410","author":"K Chamoto","year":"2017","unstructured":"Chamoto K, Al-Habsi M, Honjo T (2017) Role of PD-1 in immunity and diseases. Curr Top Microbiol Immunol 410:75\u201397","journal-title":"Curr Top Microbiol Immunol"},{"issue":"14","key":"3_CR53","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1158\/0008-5472.CAN-18-0040","volume":"78","author":"WH Yang","year":"2018","unstructured":"Yang WH, Cha JH, Xia W, Lee HH, Chan LC, Wang YN et al (2018) Juxtacrine signaling inhibits antitumor immunity by upregulating PD-L1 expression. Cancer Res 78(14):3761\u20133768","journal-title":"Cancer Res"},{"issue":"3","key":"3_CR54","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper J, Giancotti FG (2019) Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35(3):347\u2013367","journal-title":"Cancer Cell"},{"issue":"6","key":"3_CR55","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ccr.2012.11.005","volume":"22","author":"E Binda","year":"2012","unstructured":"Binda E, Visioli A, Giani F, Lamorte G, Copetti M, Pitter KL et al (2012) The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas. Cancer Cell 22(6):765\u2013780","journal-title":"Cancer Cell"},{"issue":"2","key":"3_CR56","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2013.01.007","volume":"23","author":"BW Day","year":"2013","unstructured":"Day BW, Stringer BW, Al-Ejeh F, Ting MJ, Wilson J, Ensbey KS et al (2013) EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme. Cancer Cell 23(2):238\u2013248","journal-title":"Cancer Cell"},{"issue":"3","key":"3_CR57","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3892\/ijo.2014.2519","volume":"45","author":"H Wada","year":"2014","unstructured":"Wada H, Yamamoto H, Kim C, Uemura M, Akita H, Tomimaru Y et al (2014) Association between ephrin-A1 mRNA expression and poor prognosis after hepatectomy to treat hepatocellular carcinoma. Int J Oncol 45(3):1051\u20131058","journal-title":"Int J Oncol"},{"issue":"2","key":"3_CR58","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3892\/ijo.2012.1750","volume":"42","author":"H Yamamoto","year":"2013","unstructured":"Yamamoto H, Tei M, Uemura M, Takemasa I, Uemura Y, Murata K et al (2013) Ephrin-A1 mRNA is associated with poor prognosis of colorectal cancer. Int J Oncol 42(2):549\u2013555","journal-title":"Int J Oncol"},{"issue":"3","key":"3_CR59","doi-asserted-by":"publisher","first-page":"L431","DOI":"10.1152\/ajplung.90256.2008","volume":"295","author":"J Larson","year":"2008","unstructured":"Larson J, Schomberg S, Schroeder W, Carpenter TC (2008) Endothelial EphA receptor stimulation increases lung vascular permeability. Am J Physiol Lung Cell Mol Physiol 295(3):L431\u2013L439","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"17","key":"3_CR60","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/onc.2013.180","volume":"33","author":"K Ieguchi","year":"2014","unstructured":"Ieguchi K, Tomita T, Omori T, Komatsu A, Deguchi A, Masuda J et al (2014) ADAM12-cleaved ephrin-A1 contributes to lung metastasis. Oncogene 33(17):2179\u20132190","journal-title":"Oncogene"},{"key":"3_CR61","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.1038\/ncomms9047","volume":"6","author":"O Sabet","year":"2015","unstructured":"Sabet O, Stockert R, Xouri G, Bruggemann Y, Stanoev A, Bastiaens PIH (2015) Ubiquitination switches EphA2 vesicular traffic from a continuous safeguard to a finite signalling mode. Nat Commun 6:8047","journal-title":"Nat Commun"},{"issue":"1","key":"3_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10637-012-9801-2","volume":"31","author":"CM Annunziata","year":"2013","unstructured":"Annunziata CM, Kohn EC, LoRusso P, Houston ND, Coleman RL, Buzoianu M et al (2013) Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors. Investig New Drugs 31(1):77\u201384","journal-title":"Investig New Drugs"},{"issue":"10","key":"3_CR63","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/dvg.20434","volume":"46","author":"SL Duffy","year":"2008","unstructured":"Duffy SL, Coulthard MG, Spanevello MD, Herath NI, Yeadon TM, McCarron JK et al (2008) Generation and characterization of EphA1 receptor tyrosine kinase reporter knockout mice. Genesis 46(10):553\u2013561","journal-title":"Genesis"},{"issue":"1\u20132","key":"3_CR64","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0925-4773(01)00290-8","volume":"102","author":"C Naruse-Nakajima","year":"2001","unstructured":"Naruse-Nakajima C, Asano M, Iwakura Y (2001) Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1. Mech Dev 102(1\u20132):95\u2013105","journal-title":"Mech Dev"},{"issue":"22","key":"3_CR65","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1242\/dev.074997","volume":"139","author":"R Klein","year":"2012","unstructured":"Klein R (2012) Eph\/ephrin signalling during development. Development 139(22):4105\u20134109","journal-title":"Development"},{"issue":"4","key":"3_CR66","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1242\/dev.128.4.571","volume":"128","author":"J Cooke","year":"2001","unstructured":"Cooke J, Moens C, Roth L, Durbin L, Shiomi K, Brennan C et al (2001) Eph signalling functions downstream of Val to regulate cell sorting and boundary formation in the caudal hindbrain. Development 128(4):571\u2013580","journal-title":"Development"},{"issue":"10","key":"3_CR67","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2174\/1389450116666150727115934","volume":"16","author":"SJ Riedl","year":"2015","unstructured":"Riedl SJ, Pasquale EB (2015) Targeting the Eph system with peptides and peptide conjugates. Curr Drug Targets 16(10):1031\u20131047","journal-title":"Curr Drug Targets"},{"issue":"2","key":"3_CR68","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4049\/jimmunol.1701044","volume":"200","author":"MW LaFleur","year":"2018","unstructured":"LaFleur MW, Muroyama Y, Drake CG, Sharpe AH (2018) Inhibitors of the PD-1 pathway in tumor therapy. J Immunol 200(2):375\u2013383","journal-title":"J Immunol"},{"issue":"1","key":"3_CR69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-017-0403-5","volume":"10","author":"J Wang","year":"2017","unstructured":"Wang J, Yuan R, Song W, Sun J, Liu D, Li Z (2017) PD-1, PD-L1 (B7-H1) and tumor-site immune modulation therapy: the historical perspective. J Hematol Oncol 10(1):34","journal-title":"J Hematol Oncol"},{"issue":"4","key":"3_CR70","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ijc.24798","volume":"126","author":"XD Cui","year":"2010","unstructured":"Cui XD, Lee MJ, Yu GR, Kim IH, Yu HC, Song EY et al (2010) EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma. Int J Cancer 126(4):940\u2013949","journal-title":"Int J Cancer"}],"container-title":["Advances in Experimental Medicine and Biology","Tumor Microenvironment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-47189-7_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:07:58Z","timestamp":1698300478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-47189-7_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"ISBN":["9783030471880","9783030471897"],"references-count":70,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-47189-7_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]},"assertion":[{"value":"30 October 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}